{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:22:58Z","timestamp":1757618578835,"version":"3.44.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n          <jats:p>Das Gleason-Graduierungssystem bildet die Basis der Risikostratifizierung und der klinischen Entscheidungsfindung bei Prostatakrebspatienten. In den letzten zehn Jahren haben neue Erkenntnisse \u00fcber die quantitative Einstufung und die Bedeutung bestimmter Wachstumsmuster die histopathologische Charakterisierung von Tumoren weiter optimiert. In dieser \u00dcbersichtsarbeit werden die neuesten Empfehlungen f\u00fcr die Graduierung vorgestellt und aktuelle Forschungsrichtungen er\u00f6rtert.<\/jats:p>","DOI":"10.1007\/s00292-025-01446-6","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:31:09Z","timestamp":1751427069000},"page":"267-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aktuelle Graduierung des Prostatakarzinoms","Current grading of prostate cancer. German version"],"prefix":"10.1007","volume":"46","author":[{"given":"Yosamin Gonzalez","family":"Belisario","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert J. L. H.","family":"van Leenders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"3","key":"1446_CR1","first-page":"125","volume":"50","author":"DF Gleason","year":"1966","unstructured":"Gleason\u00a0DF (1966) CLassification of prostatic carcinomas. Cancer Chemother Rep 50(3):125\u2013128","journal-title":"Cancer Chemother Rep"},{"issue":"9","key":"1446_CR2","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","volume":"29","author":"J Epstein","year":"2005","unstructured":"Epstein\u00a0J et\u00a0al (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29(9):1228\u20131242","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1446_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"J Epstein","year":"2016","unstructured":"Epstein\u00a0J et\u00a0al (2016) The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 40(2):244\u2013252","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1446_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1464-410X.2012.11611.x","volume":"111","author":"PM Pierorazio","year":"2013","unstructured":"Pierorazio\u00a0PM et\u00a0al (2013) Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. BJU Int 111(5):753\u2013760","journal-title":"BJU Int"},{"key":"1446_CR5","volume-title":"WHO classification of Tumors","author":"GJ Netto","year":"2022","unstructured":"Netto\u00a0GJ, Armin\u00a0MB, Kench\u00a0JG et\u00a0al (2022) Chapter 4: Tumours of the prostate. In: Srigley\u00a0JR, Amin\u00a0MB, Rubin\u00a0MA, Tsuzuki\u00a0T (Hrsg) WHO classification of Tumors, 5.\u00a0Aufl. Bd. 8","edition":"5"},{"issue":"8","key":"1446_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/PAS.0000000000001497","volume":"44","author":"GJLH van Leenders","year":"2020","unstructured":"van Leenders\u00a0GJLH et\u00a0al (2020) The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma. Am J Surg Pathol 44(8):87\u201399","journal-title":"Am J Surg Pathol"},{"key":"1446_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.eururo.2024.02.017","volume":"86","author":"A Cimadamore","year":"2024","unstructured":"Cimadamore\u00a0A et\u00a0al (2024) How To Report the Minor Component of a\u00a0High-grade Pattern in Radical Prostatectomy Specimens: Time To Abandon the \u201cTertiary\u201d Terminology? Eur Urol 86:291\u2013294","journal-title":"Eur Urol"},{"issue":"4","key":"1446_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.eururo.2015.10.029","volume":"69","author":"G Sauter","year":"2016","unstructured":"Sauter\u00a0G et\u00a0al (2016) Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens. Eur Urol 69(4):592\u2013598","journal-title":"Eur Urol"},{"issue":"1","key":"1446_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pathol.2018.10.003","volume":"51","author":"L Egevad","year":"2019","unstructured":"Egevad\u00a0L et\u00a0al (2019) Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR). Pathology 51(1):11\u201320","journal-title":"Pathology"},{"issue":"3","key":"1446_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00428-019-02574-0","volume":"475","author":"JG Kench","year":"2019","unstructured":"Kench\u00a0JG et\u00a0al (2019) Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting. Virchows Arch 475(3):263\u2013277","journal-title":"Virchows Arch"},{"issue":"1","key":"1446_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/ajcp\/aqad005","volume":"160","author":"J Ordner","year":"2023","unstructured":"Ordner\u00a0J et\u00a0al (2023) Significance of the Percentage of Gleason Pattern 4 at Prostate Biopsy in Predicting Adverse Pathology on Radical Prostatectomy: Application in Active Surveillance. Am J Clin Pathol 160(1):35\u201340","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"1446_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.eururo.2017.01.015","volume":"73","author":"G Sauter","year":"2018","unstructured":"Sauter\u00a0G et\u00a0al (2018) Integrating Tertiary Gleason\u00a05 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens. Eur Urol 73(5):674\u2013683","journal-title":"Eur Urol"},{"issue":"6","key":"1446_CR13","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00428-022-03301-y","volume":"480","author":"N Seyrek","year":"2022","unstructured":"Seyrek\u00a0N et\u00a0al (2022) Alternative prostate cancer grading systems incorporating percent pattern 4\/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy. Virchows Arch 480(6):1149\u20131157","journal-title":"Virchows Arch"},{"issue":"1","key":"1446_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.juro.2018.07.062","volume":"201","author":"LW Dean","year":"2019","unstructured":"Dean\u00a0LW et\u00a0al (2019) Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group\u00a02 Prostate Cancer. J\u00a0Urol 201(1):77\u201382","journal-title":"J Urol"},{"issue":"1","key":"1446_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eururo.2024.01.005","volume":"86","author":"AJ Vickers","year":"2024","unstructured":"Vickers\u00a0AJ et\u00a0al (2024) Amount of Gleason Pattern 3 Is Not Predictive of Risk in Grade Group\u00a02\u20134 Prostate Cancer. Eur Urol 86(1):1\u20133","journal-title":"Eur Urol"},{"issue":"6","key":"1446_CR16","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/modpathol.2016.49","volume":"29","author":"C Kweldam","year":"2016","unstructured":"Kweldam\u00a0C et\u00a0al (2016) Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy. Mod Pathol 29(6):630\u2013636","journal-title":"Mod Pathol"},{"key":"1446_CR17","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.ejca.2014.03.009","volume":"50","author":"D Trudel","year":"2014","unstructured":"Trudel\u00a0D et\u00a0al (2014) Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a\u00a0contemporary cohort. Eur J Cancer 50:1610\u20131616","journal-title":"Eur J Cancer"},{"issue":"8","key":"1446_CR18","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/PAS.0000000000001728","volume":"45","author":"T van der Kwast","year":"2021","unstructured":"van der Kwast\u00a0T et\u00a0al (2021) ISUP Consensus Definition of Cribriform Pattern Prostate Cancer. Am J Surg Pathol 45(8):1118\u20131126","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"1446_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/s41379-022-01009-7","volume":"35","author":"E Chan","year":"2022","unstructured":"Chan\u00a0E et\u00a0al (2022) Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25\u202fmm diameter as an optimal definition for \u201clarge\u201d cribriform prostatic adenocarcinoma. Mod Pathol 35(8):1092\u20131100","journal-title":"Mod Pathol"},{"issue":"1","key":"1446_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","volume":"32","author":"E Hollemans","year":"2018","unstructured":"Hollemans\u00a0E et\u00a0al (2018) Large cribriform growth pattern identifies ISUP grade\u00a02 prostate cancer at high risk for recurrence and metastasis. Mod Pathol 32(1):139\u2013146","journal-title":"Mod Pathol"},{"issue":"1","key":"1446_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1309\/AJCPZ7WBU9YXSJPE","volume":"136","author":"K Iczkowski","year":"2011","unstructured":"Iczkowski\u00a0K et\u00a0al (2011) Digital Quantification of Five High-Grade Prostate Cancer Patterns, Including the Cribriform Pattern, and Their Association With Adverse Outcome. Am J Clin Pathol 136(1):98\u2013107","journal-title":"Am J Clin Pathol"},{"key":"1446_CR22","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/his.15102","volume":"84","author":"N Greenland","year":"2024","unstructured":"Greenland\u00a0N et\u00a0al (2024) Large cribriform glands (\u3009\u202f0.25\u202fmm diameter) as a\u00a0predictor of adverse pathology in men with Grade Group\u00a02 prostate cancer. Histopathology 84:614\u2013623","journal-title":"Histopathology"},{"issue":"7","key":"1446_CR23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/his.14658","volume":"80","author":"L Rijstenberg","year":"2022","unstructured":"Rijstenberg\u00a0L et\u00a0al (2022) Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies. Histopathology 80(7):1041\u20131049","journal-title":"Histopathology"},{"key":"1446_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2019.07.051","volume":"77","author":"GJLH van Leenders","year":"2020","unstructured":"van Leenders\u00a0GJLH et\u00a0al (2020) Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups. Eur Urol 77:191\u2013198","journal-title":"Eur Urol"},{"issue":"1","key":"1446_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clgc.2023.07.013","volume":"22","author":"MR Downes","year":"2023","unstructured":"Downes\u00a0MR et\u00a0al (2023) Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools. Clin Genitourin Cancer 22(1):47\u201355","journal-title":"Clin Genitourin Cancer"},{"key":"1446_CR26","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/1097-0142(19861015)58:8<1714::AID-CNCR2820580823>3.0.CO;2-M","volume":"58","author":"JE McNeal","year":"1986","unstructured":"McNeal\u00a0JE et\u00a0al (1986) Cribriform Adenocarcinoma of the Prostate. Cancer 58:1714\u20131719","journal-title":"Cancer"},{"key":"1446_CR27","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/modpathol.3800702","volume":"19","author":"C Guo","year":"2006","unstructured":"Guo\u00a0C et\u00a0al (2006) Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod Pathol 19:1528\u20131535","journal-title":"Mod Pathol"},{"key":"1446_CR28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/his.13273","volume":"71","author":"R Shah","year":"2017","unstructured":"Shah\u00a0R et\u00a0al (2017) Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a\u00a0comparative clinicopathological and molecular study with a\u00a0proposal to expand the morphological spectrum of intraductal carcinoma. Histopathology 71:693\u2013702","journal-title":"Histopathology"},{"issue":"4","key":"1446_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/PAS.0000000000000794","volume":"41","author":"R Hickman","year":"2017","unstructured":"Hickman\u00a0R et\u00a0al (2017) Atypical intraductal cribriform proliferations of the prostate exhibit similar molecular and clinicopathologic characteristics as intraductal carcinoma of the prostate. Am J Surg Pathol 41(4):550\u2013556","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"1446_CR30","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1097\/PAS.0000000000000736","volume":"40","author":"J McKenney","year":"2016","unstructured":"McKenney\u00a0J et\u00a0al (2016) Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort. Am J Surg Pathol 40(11):1439\u20131456","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1446_CR31","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/his.15231","volume":"85","author":"J Nguyen","year":"2024","unstructured":"Nguyen\u00a0J et\u00a0al (2024) Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage. Histopathology 85(4):598\u2013613","journal-title":"Histopathology"},{"issue":"11","key":"1446_CR32","doi-asserted-by":"publisher","first-page":"100563","DOI":"10.1016\/j.modpat.2024.100563","volume":"37","author":"K Faryna","year":"2024","unstructured":"Faryna\u00a0K (2024) e.a, Evaluation of Artificial Intelligence-Based Gleason Grading Algorithms \u201cin the Wild\u201d. Mod Pathol 37(11):100563","journal-title":"Mod Pathol"},{"issue":"3","key":"1446_CR33","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41379-020-0640-y","volume":"34","author":"W Bulten","year":"2021","unstructured":"Bulten\u00a0W et\u00a0al (2021) Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists. Mod Pathol 34(3):660\u2013671","journal-title":"Mod Pathol"},{"issue":"1","key":"1446_CR34","doi-asserted-by":"publisher","first-page":"14904","DOI":"10.1038\/s41598-020-71942-7","volume":"10","author":"P Ambrosini","year":"2020","unstructured":"Ambrosini\u00a0P et\u00a0al (2020) Automated detection of cribriform growth patterns in prostate histology images. Sci Rep 10(1):14904","journal-title":"Sci Rep"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-025-01446-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-025-01446-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-025-01446-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:22:54Z","timestamp":1757204574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-025-01446-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1446"],"URL":"https:\/\/doi.org\/10.1007\/s00292-025-01446-6","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"type":"print","value":"2731-7188"},{"type":"electronic","value":"2731-7196"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"12 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Y.G.\u00a0Belisario und G.J.L.H.\u00a0van Leenders geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}